|
US6096318A
(en)
|
1973-05-07 |
2000-08-01 |
The Ohio State University |
Antigenically modified HCG polypeptides
|
|
US4902506A
(en)
|
1983-07-05 |
1990-02-20 |
The University Of Rochester |
Immunogenic conjugates
|
|
GB8308235D0
(en)
*
|
1983-03-25 |
1983-05-05 |
Celltech Ltd |
Polypeptides
|
|
US4816567A
(en)
*
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US5158769A
(en)
*
|
1984-03-07 |
1992-10-27 |
New York Blood Center, Inc. |
Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers
|
|
US5417986A
(en)
*
|
1984-03-16 |
1995-05-23 |
The United States Of America As Represented By The Secretary Of The Army |
Vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres
|
|
US5208036A
(en)
*
|
1985-01-07 |
1993-05-04 |
Syntex (U.S.A.) Inc. |
N-(ω, (ω-1)-dialkyloxy)- and N-(ω, (ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
|
|
US4666829A
(en)
|
1985-05-15 |
1987-05-19 |
University Of California |
Polypeptide marker for Alzheimer's disease and its use for diagnosis
|
|
DE3521994A1
(de)
|
1985-06-20 |
1987-01-02 |
Bayer Ag |
N-(2-aminoacylamido-2-desoxy-hexosyl)-amide-, -carbamate und -harnstoffe, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
|
|
US5618920A
(en)
*
|
1985-11-01 |
1997-04-08 |
Xoma Corporation |
Modular assembly of antibody genes, antibodies prepared thereby and use
|
|
DE3689123T2
(de)
|
1985-11-01 |
1994-03-03 |
Xoma Corp |
Modulare einheit von antikörpergenen, daraus hergestellte antikörper und verwendung.
|
|
US4713366A
(en)
|
1985-12-04 |
1987-12-15 |
The Ohio State University Research Foundation |
Antigenic modification of polypeptides
|
|
US5096706A
(en)
*
|
1986-03-25 |
1992-03-17 |
National Research Development Corporation |
Antigen-based treatment for adiposity
|
|
US6548640B1
(en)
*
|
1986-03-27 |
2003-04-15 |
Btg International Limited |
Altered antibodies
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
JPS62267297A
(ja)
|
1986-05-15 |
1987-11-19 |
Tokyo Met Gov Seishin Igaku Sogo Kenkyusho |
老人斑反応性モノクロ−ナル抗体、それを産生する細胞株及び該モノクロ−ナル抗体の製造方法
|
|
US5278049A
(en)
*
|
1986-06-03 |
1994-01-11 |
Incyte Pharmaceuticals, Inc. |
Recombinant molecule encoding human protease nexin
|
|
US5231170A
(en)
|
1986-08-27 |
1993-07-27 |
Paul Averback |
Antibodies to dense microspheres
|
|
US5220013A
(en)
|
1986-11-17 |
1993-06-15 |
Scios Nova Inc. |
DNA sequence useful for the detection of Alzheimer's disease
|
|
US5187153A
(en)
*
|
1986-11-17 |
1993-02-16 |
Scios Nova Inc. |
Methods of treatment using Alzheimer's amyloid polypeptide derivatives
|
|
US5223482A
(en)
|
1986-11-17 |
1993-06-29 |
Scios Nova Inc. |
Recombinant Alzheimer's protease inhibitory amyloid protein and method of use
|
|
US4879213A
(en)
|
1986-12-05 |
1989-11-07 |
Scripps Clinic And Research Foundation |
Synthetic polypeptides and antibodies related to Epstein-Barr virus early antigen-diffuse
|
|
DE3702789A1
(de)
|
1987-01-30 |
1988-08-18 |
Bayer Ag |
Vorlaeuferprotein des apc-polypeptids, dafuer codierende dna und diagnostische verwendung der dna und des proteins
|
|
US4912206A
(en)
*
|
1987-02-26 |
1990-03-27 |
The United States Of America As Represented By The Department Of Health And Human Services |
CDNA clone encoding brain amyloid of alzheimer's disease
|
|
JP3101690B2
(ja)
|
1987-03-18 |
2000-10-23 |
エス・ビィ・２・インコーポレイテッド |
変性抗体の、または変性抗体に関する改良
|
|
JPS63245689A
(ja)
|
1987-03-31 |
1988-10-12 |
Suntory Ltd |
ヒトアミロイド関連蛋白モノクロ−ナル抗体
|
|
US4883666A
(en)
|
1987-04-29 |
1989-11-28 |
Massachusetts Institute Of Technology |
Controlled drug delivery system for treatment of neural disorders
|
|
US5258498A
(en)
|
1987-05-21 |
1993-11-02 |
Creative Biomolecules, Inc. |
Polypeptide linkers for production of biosynthetic proteins
|
|
US5245015A
(en)
|
1991-04-26 |
1993-09-14 |
Tanox Biosystems, Inc. |
Monoclonal antibodies which neutralize HIV-1 through reaction with a conformational epitope in vitro
|
|
US5057540A
(en)
|
1987-05-29 |
1991-10-15 |
Cambridge Biotech Corporation |
Saponin adjuvant
|
|
US5583112A
(en)
|
1987-05-29 |
1996-12-10 |
Cambridge Biotech Corporation |
Saponin-antigen conjugates and the use thereof
|
|
US5849298A
(en)
*
|
1987-06-24 |
1998-12-15 |
Autoimmune Inc. |
Treatment of multiple sclerosis by oral administration of bovine myelin
|
|
JP2512796B2
(ja)
|
1987-06-24 |
1996-07-03 |
オートイミュン・インコーポレイテッド |
自己抗原の経口投与による自己免疫疾患の治療法
|
|
US5645820A
(en)
|
1987-06-24 |
1997-07-08 |
Autoimmune, Inc. |
Treatment of autoimmune diseases by aerosol administration of autoantigens
|
|
US5571499A
(en)
|
1987-06-24 |
1996-11-05 |
Autoimmune, Inc. |
Treatment of autoimmune diseases by aerosol administration of autoantigens
|
|
US5869054A
(en)
*
|
1987-06-24 |
1999-02-09 |
Autoimmune Inc. |
Treatment of multiple sclerosis by oral administration of autoantigens
|
|
US5641474A
(en)
|
1987-06-24 |
1997-06-24 |
Autoimmune, Inc. |
Prevention of autoimmune diseases by aerosol administration of autoantigens
|
|
US5571500A
(en)
|
1987-06-24 |
1996-11-05 |
Autoimmune, Inc. |
Treatment of autoimmune diseases through administration by inhalation of autoantigens
|
|
US5004697A
(en)
|
1987-08-17 |
1991-04-02 |
Univ. Of Ca |
Cationized antibodies for delivery through the blood-brain barrier
|
|
US4966753A
(en)
|
1987-08-18 |
1990-10-30 |
Molecular Rx, Inc. |
Immunotherapeutic methods and compositions employing antigens characteristic of malignant neoplasms
|
|
US5677425A
(en)
|
1987-09-04 |
1997-10-14 |
Celltech Therapeutics Limited |
Recombinant antibody
|
|
US5336603A
(en)
|
1987-10-02 |
1994-08-09 |
Genentech, Inc. |
CD4 adheson variants
|
|
CA1339014C
(en)
|
1987-10-08 |
1997-03-25 |
Ronald E. Majocha |
Antibodies to a4 amyloid peptide
|
|
US5231000A
(en)
|
1987-10-08 |
1993-07-27 |
The Mclean Hospital |
Antibodies to A4 amyloid peptide
|
|
AU2728588A
(en)
|
1987-10-23 |
1989-05-23 |
Genetics Institute Inc. |
Composition and method for treating cancers characterized by over-expression of the c-fms proto-oncogene
|
|
US5089603A
(en)
*
|
1989-06-21 |
1992-02-18 |
Tanox Biosystems, Inc. |
Antigenic epitopes present on membrane-bound but not secreted iga
|
|
WO1989006689A1
(en)
|
1988-01-13 |
1989-07-27 |
The Mclean Hospital Corporation |
Genetic constructs containing the alzheimer brain amyloid gene
|
|
US4912094B1
(en)
|
1988-06-29 |
1994-02-15 |
Ribi Immunochem Research Inc. |
Modified lipopolysaccharides and process of preparation
|
|
US5576184A
(en)
|
1988-09-06 |
1996-11-19 |
Xoma Corporation |
Production of chimeric mouse-human antibodies with specificity to human tumor antigens
|
|
KR900005995A
(ko)
|
1988-10-31 |
1990-05-07 |
우메모또 요시마사 |
변형 인터류킨-2 및 그의 제조방법
|
|
EP0442926A1
(en)
|
1988-11-10 |
1991-08-28 |
Imperial Cancer Research Technology Limited |
Polypeptides
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
IL162181A
(en)
|
1988-12-28 |
2006-04-10 |
Pdl Biopharma Inc |
A method of producing humanized immunoglubulin, and polynucleotides encoding the same
|
|
US5227159A
(en)
|
1989-01-31 |
1993-07-13 |
Miller Richard A |
Anti-idiotype antibodies reactive with shared idiotopes expressed by B cell lymphomas and autoantibodies
|
|
US5262332A
(en)
|
1989-04-05 |
1993-11-16 |
Brigham And Women's Hospital |
Diagnostic method for Alzheimer's disease: examination of non-neural tissue
|
|
WO1990012871A1
(en)
|
1989-04-14 |
1990-11-01 |
Research Foundation For Mental Hygiene, Inc. |
Cerebrovascular amyloid protein-specific monoclonal antibody sv17-6e10
|
|
WO1990012870A1
(en)
|
1989-04-14 |
1990-11-01 |
Research Foundation For Mental Hygiene, Inc. |
Monoclonal antibody to amyloid peptide
|
|
EP0394827A1
(en)
|
1989-04-26 |
1990-10-31 |
F. Hoffmann-La Roche Ag |
Chimaeric CD4-immunoglobulin polypeptides
|
|
WO1990014837A1
(en)
|
1989-05-25 |
1990-12-13 |
Chiron Corporation |
Adjuvant formulation comprising a submicron oil droplet emulsion
|
|
JPH0319929A
(ja)
|
1989-06-14 |
1991-01-29 |
Asahi Chem Ind Co Ltd |
オープンエンド紡績の糸
|
|
US5112946A
(en)
|
1989-07-06 |
1992-05-12 |
Repligen Corporation |
Modified pf4 compositions and methods of use
|
|
DK0506785T3
(da)
|
1989-12-20 |
2000-07-24 |
Autoimmune Inc |
Forbedret behandling af autoimmune sygdomme ved aerosol-administration af autoantigener
|
|
US5859205A
(en)
*
|
1989-12-21 |
1999-01-12 |
Celltech Limited |
Humanised antibodies
|
|
GB8928874D0
(en)
|
1989-12-21 |
1990-02-28 |
Celltech Ltd |
Humanised antibodies
|
|
EP1690935A3
(en)
|
1990-01-12 |
2008-07-30 |
Abgenix, Inc. |
Generation of xenogeneic antibodies
|
|
HUT61896A
(en)
|
1990-03-02 |
1993-03-29 |
Autoimmune Inc |
Process for producing orally administrable pharmaceutical compositions comprising autoantigenes, suitable for improving down-control of autoimmune diseases
|
|
EP0451700A1
(en)
|
1990-04-10 |
1991-10-16 |
Miles Inc. |
Recombinant APP minigenes for expression in transgenic mice as models for Alzheimers's disease
|
|
WO1991016628A1
(en)
|
1990-04-24 |
1991-10-31 |
The Regents Of The University Of California |
Purification, detection and methods of use of protease nexin-2
|
|
JP2703096B2
(ja)
|
1990-04-26 |
1998-01-26 |
三菱重工業株式会社 |
コンベア付きロボットシステムの教示方法
|
|
GB9009548D0
(en)
|
1990-04-27 |
1990-06-20 |
Celltech Ltd |
Chimeric antibody and method
|
|
US5753624A
(en)
*
|
1990-04-27 |
1998-05-19 |
Milkhaus Laboratory, Inc. |
Materials and methods for treatment of plaquing disease
|
|
JP2980677B2
(ja)
|
1990-04-27 |
1999-11-22 |
マクマイケル，ジョン |
不正常なアミロイドβタンパク質と関連する中枢神経系疾患状態の治療のための方法および組成物
|
|
US5427908A
(en)
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
|
JPH0415492A
(ja)
|
1990-05-10 |
1992-01-20 |
Mitsubishi Electric Corp |
磁石発電機の冷却ファンおよびその製造方法
|
|
US5349053A
(en)
|
1990-06-01 |
1994-09-20 |
Protein Design Labs, Inc. |
Chimeric ligand/immunoglobulin molecules and their uses
|
|
JPH06507782A
(ja)
*
|
1990-06-15 |
1994-09-08 |
サイオス ノバ インコーポレイテッド |
アルツハイマー病のアミロイド形成開症状を示すヒト以外の組換え哺乳動物
|
|
EP0537247A4
(en)
|
1990-06-19 |
1993-09-08 |
Immuvax |
Nonpathogenic variant virus
|
|
GB9014932D0
(en)
|
1990-07-05 |
1990-08-22 |
Celltech Ltd |
Recombinant dna product and method
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
US5780587A
(en)
|
1990-08-24 |
1998-07-14 |
President And Fellows Of Harvard College |
Compounds and methods for inhibiting β-protein filament formation and neurotoxicity
|
|
US5814318A
(en)
|
1990-08-29 |
1998-09-29 |
Genpharm International Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5874299A
(en)
|
1990-08-29 |
1999-02-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
ES2246502T3
(es)
|
1990-08-29 |
2006-02-16 |
Genpharm International, Inc. |
Animales no humanos transgenicos capaces de producir anticuerpos heterologos.
|
|
US5789650A
(en)
|
1990-08-29 |
1998-08-04 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5770429A
(en)
|
1990-08-29 |
1998-06-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
US5877397A
(en)
|
1990-08-29 |
1999-03-02 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
NZ239643A
(en)
|
1990-09-17 |
1996-05-28 |
North American Vaccine Inc |
Vaccine containing bacterial polysaccharide protein conjugate and adjuvant (c-nd-che-a-co-b-r) with a long chain alkyl group.
|
|
US6506728B2
(en)
|
1990-09-25 |
2003-01-14 |
Genentech, Inc. |
Methods using a novel neurotrophic factor, NT-4
|
|
CA2092823A1
(en)
|
1990-09-28 |
1992-03-29 |
Barry D. Greenberg |
Transgenic animals with alzheimer's amyloid precursor gene
|
|
DK0553244T4
(da)
|
1990-10-05 |
2005-08-01 |
Celldex Therapeutics Inc |
Målrettet immunostimulering med bispecifikke reagenser
|
|
CA2092905C
(en)
|
1990-10-15 |
2002-01-08 |
Howard L. Weiner |
Treatment of autoimmune diseases by oral administration of autoantigens
|
|
GB9023352D0
(en)
|
1990-10-26 |
1990-12-05 |
Lynxvale Ltd |
Vaccinia vectors,vaccinia genes and expression products thereof
|
|
ATE145428T1
(de)
|
1990-12-14 |
1996-12-15 |
Cell Genesys Inc |
Chimärische ketten zur transduktion von rezeptorverbundenen signalwegen
|
|
AU652997B2
(en)
|
1991-01-21 |
1994-09-15 |
Elan Pharmaceuticals, Inc. |
Test and model for alzheimer's disease
|
|
ES2149166T3
(es)
|
1991-03-01 |
2000-11-01 |
Merial Sas |
Procedimiento de inmunoneutralizacion anti-lhrm de los animales domesticos machos no castrados y peptido para su realizacion.
|
|
US5192753A
(en)
*
|
1991-04-23 |
1993-03-09 |
Mcgeer Patrick L |
Anti-rheumatoid arthritic drugs in the treatment of dementia
|
|
CA2086831C
(en)
|
1991-05-08 |
1999-03-16 |
Reinhard Gluck |
Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them
|
|
WO1994004679A1
(en)
*
|
1991-06-14 |
1994-03-03 |
Genentech, Inc. |
Method for making humanized antibodies
|
|
EP0590058B1
(en)
|
1991-06-14 |
2003-11-26 |
Genentech, Inc. |
HUMANIZED Heregulin ANTIBODy
|
|
US5844095A
(en)
|
1991-06-27 |
1998-12-01 |
Bristol-Myers Squibb Company |
CTLA4 Ig fusion proteins
|
|
US5672805A
(en)
|
1991-07-18 |
1997-09-30 |
The Regents Of The University Of California |
Transgenic mice expressing the neurotoxic C-terminus of β-amyloid precursor protein
|
|
JP2966592B2
(ja)
|
1991-07-20 |
1999-10-25 |
萩原 義秀 |
安定化されたヒトモノクローナル抗体製剤
|
|
US5434050A
(en)
|
1991-08-13 |
1995-07-18 |
Regents Of The University Of Minnesota |
Labelled β-amyloid peptide and methods of screening for Alzheimer's disease
|
|
US5837268A
(en)
|
1991-10-16 |
1998-11-17 |
University Of Saskatchewan |
GnRH-leukotoxin chimeras
|
|
JPH07503132A
(ja)
|
1991-12-17 |
1995-04-06 |
ジェンファーム インターナショナル，インコーポレイティド |
異種抗体を産生することができるトランスジェニック非ヒト動物
|
|
DE69233109T2
(de)
|
1992-01-07 |
2004-05-19 |
Elan Pharmaceuticals, Inc., San Francisco |
Transgene tiermodelle fur alzheimer-krankheit
|
|
US5622929A
(en)
|
1992-01-23 |
1997-04-22 |
Bristol-Myers Squibb Company |
Thioether conjugates
|
|
US5679348A
(en)
|
1992-02-03 |
1997-10-21 |
Cedars-Sinai Medical Center |
Immunotherapy for recurrent HSV infections
|
|
EP0625910B1
(en)
|
1992-02-11 |
2003-07-23 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Dual carrier immunogenic construct
|
|
BR9306042A
(pt)
|
1992-02-28 |
1997-11-18 |
Autoimmune Inc |
Método para tratar uma doença auto-immune em um mamifero e formas de dosagens farmacêuticas oral e inalável
|
|
US5714350A
(en)
|
1992-03-09 |
1998-02-03 |
Protein Design Labs, Inc. |
Increasing antibody affinity by altering glycosylation in the immunoglobulin variable region
|
|
EP0561087B1
(en)
|
1992-03-20 |
1999-08-04 |
N.V. Innogenetics S.A. |
Mutated form of the beta-amyloid precursor protein gene
|
|
US5447851B1
(en)
|
1992-04-02 |
1999-07-06 |
Univ Texas System Board Of |
Dna encoding a chimeric polypeptide comprising the extracellular domain of tnf receptor fused to igg vectors and host cells
|
|
US5604102A
(en)
|
1992-04-15 |
1997-02-18 |
Athena Neurosciences, Inc. |
Methods of screening for β-amyloid peptide production inhibitors
|
|
US5441870A
(en)
|
1992-04-15 |
1995-08-15 |
Athena Neurosciences, Inc. |
Methods for monitoring cellular processing of β-amyloid precursor protein
|
|
US5851787A
(en)
*
|
1992-04-20 |
1998-12-22 |
The General Hospital Corporation |
Nucleic acid encoding amyloid precursor-like protein and uses thereof
|
|
AU4116793A
(en)
|
1992-04-24 |
1993-11-29 |
Board Of Regents, The University Of Texas System |
Recombinant production of immunoglobulin-like domains in prokaryotic cells
|
|
GB9209118D0
(en)
|
1992-04-28 |
1992-06-10 |
Sb 120 Amsterdam Bv |
Vaccine compositions
|
|
DK0652758T3
(da)
*
|
1992-06-18 |
2000-05-08 |
Harvard College |
Diferitoxin-vacciner
|
|
DE69313134T2
(de)
|
1992-06-25 |
1998-02-26 |
Smithkline Beecham Biolog |
Adjuvantien enthaltende impfstoffzusammensetzung
|
|
US6610493B1
(en)
|
1993-06-17 |
2003-08-26 |
Brigham And Women's Hospital |
Screening compounds for the ability to alter the production of amyloid-β peptide
|
|
US5766846A
(en)
|
1992-07-10 |
1998-06-16 |
Athena Neurosciences |
Methods of screening for compounds which inhibit soluble β-amyloid peptide production
|
|
US5837672A
(en)
|
1992-07-10 |
1998-11-17 |
Athena Neurosciences, Inc. |
Methods and compositions for the detection of soluble β-amyloid peptide
|
|
WO1994001772A1
(en)
|
1992-07-13 |
1994-01-20 |
The Children's Medical Center Corporation |
SCREEN FOR ALZHEIMER'S DISEASE THERAPEUTICS BASED ON β-AMYLOID PRODUCTION
|
|
IL102687A
(en)
|
1992-07-30 |
1997-06-10 |
Yeda Res & Dev |
Conjugates of poorly immunogenic antigens and synthetic pepide carriers and vaccines comprising them
|
|
CA2141427C
(en)
|
1992-07-31 |
2008-07-22 |
Mohammed Anjam Khan |
Expression of recombinant fusion proteins in attenuated bacteria
|
|
KR950702839A
(ko)
|
1992-08-27 |
1995-08-23 |
스티븐 딕 |
레트로, 인버소-, 및 레트로- 인버소 합성 펩티드 유사체(retro-, inverso-, and retro-inverso synthetic peptide analogues)
|
|
US5958883A
(en)
|
1992-09-23 |
1999-09-28 |
Board Of Regents Of The University Of Washington Office Of Technology |
Animal models of human amyloidoses
|
|
AU5358494A
(en)
|
1992-10-13 |
1994-05-09 |
Duke University |
Method of inhibiting binding of amyloid precursor protein to beta-amyloid protein
|
|
US5605811A
(en)
*
|
1992-10-26 |
1997-02-25 |
Athena Neurosciences, Inc. |
Methods and compositions for monitoring cellular processing of beta-amyloid precursor protein
|
|
WO1994010569A1
(en)
|
1992-10-26 |
1994-05-11 |
Schenk Dale B |
METHODS AND COMPOSITIONS FOR THE DETECTION OF SOLUBLE β-AMYLOID PEPTIDE
|
|
US5972336A
(en)
|
1992-11-03 |
1999-10-26 |
Oravax Merieux Co. |
Urease-based vaccine against helicobacter infection
|
|
US6210671B1
(en)
*
|
1992-12-01 |
2001-04-03 |
Protein Design Labs, Inc. |
Humanized antibodies reactive with L-selectin
|
|
DE69432513T2
(de)
|
1993-01-22 |
2003-12-24 |
Sloan-Kettering Institute For Cancer Research, New York |
Gangliosid-klh-konjugatimastoffe mit qs-21
|
|
US5955317A
(en)
|
1993-01-25 |
1999-09-21 |
Takeda Chemical Industries, Ltd. |
Antibodies to β-amyloids or their derivatives and use thereof
|
|
EP0683234B2
(en)
|
1993-01-25 |
2007-06-06 |
Takeda Chemical Industries, Ltd. |
Antibody against beta-amyloid or their derivative and use thereof
|
|
US5358708A
(en)
|
1993-01-29 |
1994-10-25 |
Schering Corporation |
Stabilization of protein formulations
|
|
US5472693A
(en)
|
1993-02-16 |
1995-12-05 |
The Dow Chemical Company |
Family of anti-carcinoembryonic antigen chimeric antibodies
|
|
DE614989T1
(de)
*
|
1993-02-17 |
1995-09-28 |
Morphosys Proteinoptimierung |
Verfahren für in vivo Selektion von Ligandenbindende Proteine.
|
|
CA2115900A1
(en)
|
1993-02-22 |
1994-08-23 |
Gerald W. Becker |
Pharmaceutical screens and antibodies
|
|
AU692152B2
(en)
*
|
1993-03-17 |
1998-06-04 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatments
|
|
AU6414994A
(en)
|
1993-03-18 |
1994-10-11 |
Cytimmune Sciences, Inc. |
Composition and method for reducing toxicity of biologically-active factors
|
|
KR100310510B1
(ko)
|
1993-03-23 |
2002-07-04 |
장 스테판느 |
3-0-탈아세틸화모노포스포릴지질a를함유하는백신조성물
|
|
CA2119090A1
(en)
|
1993-03-26 |
1994-09-27 |
Wayne R. Gombotz |
Compositions for controlled release of biologically active tgf-.beta.
|
|
WO1994025591A1
(en)
|
1993-04-29 |
1994-11-10 |
Unilever N.V. |
PRODUCTION OF ANTIBODIES OR (FUNCTIONALIZED) FRAGMENTS THEREOF DERIVED FROM HEAVY CHAIN IMMUNOGLOBULINS OF $i(CAMELIDAE)
|
|
IT1270939B
(it)
|
1993-05-11 |
1997-05-26 |
Angeletti P Ist Richerche Bio |
Procedimento per la preparazione di immunogeni e reagenti diagnostici,e immunogeni e reagenti diagnostici cosi' ottenibili.
|
|
RU2160119C2
(ru)
*
|
1993-05-25 |
2000-12-10 |
Американ Цианамид Компани |
Вакцинная композиция, содержащая белок респираторно-синцитиального вируса (варианты)
|
|
WO1994028412A1
(en)
|
1993-05-28 |
1994-12-08 |
The Miriam Hospital |
Composition and method for in vivo imaging of amyloid deposits
|
|
EP0700445B1
(en)
|
1993-06-04 |
2002-01-23 |
Whitehead Institute For Biomedical Research |
Stress proteins and uses therefor
|
|
GR1001607B
(el)
|
1993-06-10 |
1994-06-30 |
Lucet Beatrice Yvette Michele |
Πλωτό σύστημα υποστήριξης φραγμάτων με απορροφητικά υλικά για την αντιρρυπαντική προστασία κλειστών ή ημίκλειστων υδάτινων συστημάτων από επιπλέοντες υδρογονάν?ρακες.
|
|
US5464823A
(en)
|
1993-07-20 |
1995-11-07 |
The Regents Of The University Of California |
Mammalian antibiotic peptides
|
|
JPH09500540A
(ja)
|
1993-07-30 |
1997-01-21 |
メデヴァ ホールディングス ビー．ヴイ． |
ワクチン組成物
|
|
CA2146667A1
(en)
|
1993-08-18 |
1995-02-23 |
Adolf Hoess |
Lipopolysaccharide-binding and neutralizing peptides
|
|
US6538624B1
(en)
*
|
1993-08-20 |
2003-03-25 |
Seiko Epson Corporation |
Head-mounted image display apparatus
|
|
JPH09501936A
(ja)
|
1993-08-26 |
1997-02-25 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
生物活性ペプチドをコードする裸のポリヌクレオチドを投与するための方法、組成物および装置
|
|
DK96493D0
(da)
|
1993-08-26 |
1993-08-26 |
Mouritsen Og Elsner Aps |
Fremgangsmaade til at inducere antistofresponser mod selvproteiner og autovaccine fremstillet ved fremgangsmaaden
|
|
WO1995006407A1
(en)
|
1993-08-30 |
1995-03-09 |
The Regents Of The University Of California |
Novel component of amyloid in alzheimer's disease and methods for use of same
|
|
AP583A
(en)
|
1993-09-07 |
1997-04-14 |
Smithkline Beecham Corp |
Recombination IL4 antibodies useful in treatment of IL4 mediated disorders.
|
|
US5652334A
(en)
|
1993-09-08 |
1997-07-29 |
City Of Hope |
Method for design of substances that enhance memory and improve the quality of life
|
|
US5385887A
(en)
*
|
1993-09-10 |
1995-01-31 |
Genetics Institute, Inc. |
Formulations for delivery of osteogenic proteins
|
|
CN1135181A
(zh)
|
1993-09-14 |
1996-11-06 |
Cytel有限公司 |
使用泛dr结合肽改变免疫应答
|
|
US5470951A
(en)
|
1993-09-29 |
1995-11-28 |
City Of Hope |
Peptides for antagonizing the effects of amyloid βprotein
|
|
US5858981A
(en)
*
|
1993-09-30 |
1999-01-12 |
University Of Pennsylvania |
Method of inhibiting phagocytosis
|
|
AU683703B2
(en)
|
1993-10-20 |
1997-11-20 |
Duke University |
Method of binding material to the beta-amyloid peptide
|
|
WO1995011008A2
(en)
|
1993-10-22 |
1995-04-27 |
Genentech, Inc. |
Methods and compositions for microencapsulation of adjuvants
|
|
JP3504963B2
(ja)
|
1993-10-22 |
2004-03-08 |
智靖 羅 |
抗ヒト高親和性ＩｇＥ受容体モノクローナル抗体に係るアミノ酸配列をコードするＤＮＡ断片
|
|
US5744368A
(en)
|
1993-11-04 |
1998-04-28 |
Research Foundation Of State University Of New York |
Methods for the detection of soluble amyloid β-protein (βAP) or soluble transthyretin (TTR)
|
|
JPH07132033A
(ja)
|
1993-11-12 |
1995-05-23 |
Hoechst Japan Ltd |
アルツハイマー病モデルトランスジェニック動物
|
|
US5827690A
(en)
|
1993-12-20 |
1998-10-27 |
Genzyme Transgenics Corporatiion |
Transgenic production of antibodies in milk
|
|
GB9326253D0
(en)
|
1993-12-23 |
1994-02-23 |
Smithkline Beecham Biolog |
Vaccines
|
|
US5434170A
(en)
|
1993-12-23 |
1995-07-18 |
Andrulis Pharmaceuticals Corp. |
Method for treating neurocognitive disorders
|
|
US5877399A
(en)
*
|
1994-01-27 |
1999-03-02 |
Johns Hopkins University |
Transgenic mice expressing APP-Swedish mutation develop progressive neurologic disease
|
|
WO1995020666A2
(en)
|
1994-01-27 |
1995-08-03 |
Regents Of The University Of Minnesota |
Transgenic non-human mammals with progressive neurologic disease
|
|
JPH09511492A
(ja)
|
1994-02-03 |
1997-11-18 |
ザ ピコワー インスティテュート フォア メディカル リサーチ |
アミロイドーシスの前進性グリコシル化終末産物仲介モジュレーション用組成物及び方法
|
|
AUPM411994A0
(en)
|
1994-02-25 |
1994-03-24 |
Deakin Research Limited |
Epitopes
|
|
US5795954A
(en)
|
1994-03-04 |
1998-08-18 |
Genentech, Inc. |
Factor VIIa inhibitors from Kunitz domain proteins
|
|
US6270757B1
(en)
|
1994-04-21 |
2001-08-07 |
Genetics Institute, Inc. |
Formulations for IL-11
|
|
US6372716B1
(en)
*
|
1994-04-26 |
2002-04-16 |
Genetics Institute, Inc. |
Formulations for factor IX
|
|
EP0760676B1
(en)
|
1994-05-25 |
2001-07-11 |
McMICHAEL, John |
Materials and methods for treatment of plaquing diseases
|
|
US5622701A
(en)
*
|
1994-06-14 |
1997-04-22 |
Protein Design Labs, Inc. |
Cross-reacting monoclonal antibodies specific for E- and P-selectin
|
|
US5798100A
(en)
|
1994-07-06 |
1998-08-25 |
Immunomedics, Inc. |
Multi-stage cascade boosting vaccine
|
|
US6417178B1
(en)
|
1994-07-19 |
2002-07-09 |
University Of Pittsburgh |
Amyloid binding nitrogen-linked compounds for the antemortem diagnosis of alzheimer's disease, in vivo imaging and prevention of amyloid deposits
|
|
WO1996003144A1
(en)
|
1994-07-27 |
1996-02-08 |
The Council Of The Queensland Institute Of Medical Research |
Polyepitope vaccines
|
|
GB9415379D0
(en)
|
1994-07-29 |
1994-09-21 |
Smithkline Beecham Plc |
Novel compounds
|
|
EP0784684B8
(en)
|
1994-09-16 |
2008-03-26 |
Cancer Research Institute of Contra Costa |
RECOMBINANT PEPTIDES DERIVED FROM THE Mc3 ANTI-BA46 ANTIBODY, METHODS OF USE THEREOF, AND METHODS OF HUMANIZING ANTIBODY PEPTIDES
|
|
US5872005A
(en)
|
1994-11-03 |
1999-02-16 |
Cell Genesys Inc. |
Packaging cell lines for adeno-associated viral vectors
|
|
US6114133A
(en)
|
1994-11-14 |
2000-09-05 |
Elan Pharmaceuticals, Inc. |
Methods for aiding in the diagnosis of Alzheimer's disease by measuring amyloid-β peptide (x-≧41)
|
|
US5589154A
(en)
|
1994-11-22 |
1996-12-31 |
Rutgers, The State University Of New Jersey |
Methods for the prevention or treatment of vascular hemorrhaging and Alzheimer's disease
|
|
US5688651A
(en)
|
1994-12-16 |
1997-11-18 |
Ramot University Authority For Applied Research And Development Ltd. |
Prevention of protein aggregation
|
|
US5612030A
(en)
|
1995-01-17 |
1997-03-18 |
University Of Kentucky Research Foundation |
Anti-idiotype monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma
|
|
JP2000510813A
(ja)
*
|
1995-02-06 |
2000-08-22 |
ジェネテイックス・インスティテュート・インコーポレイテッド |
Ｉｌ−１２用処方
|
|
US5786180A
(en)
|
1995-02-14 |
1998-07-28 |
Bayer Corporation |
Monoclonal antibody 369.2B specific for β A4 peptide
|
|
US5624937A
(en)
*
|
1995-03-02 |
1997-04-29 |
Eli Lilly And Company |
Chemical compounds as inhibitors of amyloid beta protein production
|
|
US5854215A
(en)
|
1995-03-14 |
1998-12-29 |
Praecis Pharmaceuticals Incorporated |
Modulators of β-amyloid peptide aggregation
|
|
US5817626A
(en)
|
1995-03-14 |
1998-10-06 |
Praecis Pharmaceuticals Incorporated |
Modulators of beta-amyloid peptide aggregation
|
|
CA2214247C
(en)
|
1995-03-14 |
2004-02-10 |
Praecis Pharmaceuticals Incorporated |
Modulators of amyloid aggregation
|
|
US6303567B1
(en)
|
1995-03-14 |
2001-10-16 |
Praecis Pharmaceuticals, Inc . |
Modulators of β-amyloid peptide aggregation comprising D-amino acids
|
|
AU711702B2
(en)
|
1995-03-23 |
1999-10-21 |
Cambridge University Technical Services Limited |
Vectors for gene delivery
|
|
US5869046A
(en)
*
|
1995-04-14 |
1999-02-09 |
Genentech, Inc. |
Altered polypeptides with increased half-life
|
|
US6121022A
(en)
|
1995-04-14 |
2000-09-19 |
Genentech, Inc. |
Altered polypeptides with increased half-life
|
|
UA56132C2
(uk)
|
1995-04-25 |
2003-05-15 |
Смітклайн Бічем Байолоджікалс С.А. |
Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
|
|
WO1996037621A2
(en)
|
1995-05-23 |
1996-11-28 |
Morphosys Gesellschaft Für Proteinoptimierung Mbh |
Multimeric proteins
|
|
WO1996039176A1
(en)
|
1995-06-05 |
1996-12-12 |
Brigham & Women's Hospital |
USE OF ORAL TOLERANCE TO SUPPRESS BOTH Th1 AND Th2 IMMUNE RESPONSES AND TO SUPPRESS ANTIBODY PRODUCTION
|
|
US5948763A
(en)
|
1995-06-07 |
1999-09-07 |
New York University |
Peptides and pharmaceutical compositions thereof for treatment of disorders or diseases associated with abnormal protein folding into amyloid or amyloid-like deposits
|
|
CA2221986A1
(en)
|
1995-06-07 |
1996-12-19 |
Athena Neurosciences, Inc. |
Method for identifying alzheimer's disease therapeutics using transgenic animal models
|
|
US5910427A
(en)
|
1995-06-22 |
1999-06-08 |
La Jolla Institute For Allergy And Immunology |
Antigen non-specific glycosylation inhibiting factor derivatives
|
|
ATE214603T1
(de)
|
1995-06-30 |
2002-04-15 |
American Cyanamid Co |
Stabile makrolide und makrolide imptstoff- zusammensetzungen
|
|
DE69635207T2
(de)
|
1995-07-07 |
2006-06-22 |
Darwin Molecular Corp. |
Auf Chromosom 1 lokalisiertes Gen dessen Genprodukt mit der Alzheimerschen Krankheit assoziiert ist.
|
|
US6685940B2
(en)
|
1995-07-27 |
2004-02-03 |
Genentech, Inc. |
Protein formulation
|
|
AUPN443995A0
(en)
|
1995-07-27 |
1995-08-17 |
Csl Limited |
Papillomavirus polyprotein
|
|
US6267958B1
(en)
|
1995-07-27 |
2001-07-31 |
Genentech, Inc. |
Protein formulation
|
|
EP0859841B1
(en)
|
1995-08-18 |
2002-06-19 |
MorphoSys AG |
Protein/(poly)peptide libraries
|
|
US5824322A
(en)
|
1995-08-21 |
1998-10-20 |
Cytrx Corporation |
Compositions and methods for growth promotion
|
|
EP1416280A3
(en)
|
1995-09-14 |
2005-08-10 |
The Regents of the University of California |
Antibodies specific for native PrPsc
|
|
US5731284A
(en)
*
|
1995-09-28 |
1998-03-24 |
Amgen Inc. |
Method for treating Alzheimer's disease using glial line-derived neurotrophic factor (GDNF) protein product
|
|
EP0854919A1
(en)
|
1995-10-10 |
1998-07-29 |
Novartis AG |
Melanoma-associated protein
|
|
US5985242A
(en)
|
1995-10-27 |
1999-11-16 |
Praecis Pharmaceuticals, Inc. |
Modulators of β-amyloid peptide aggregation comprising D-amino acids
|
|
US5750361A
(en)
*
|
1995-11-02 |
1998-05-12 |
The Regents Of The University Of California |
Formation and use of prion protein (PRP) complexes
|
|
NZ322175A
(en)
|
1995-11-10 |
1999-02-25 |
Elan Corp Plc |
Peptides which enhance transport across tissues and methods of identifying the same
|
|
WO1997018855A1
(en)
|
1995-11-21 |
1997-05-29 |
Eduard Naumovich Lerner |
Device for enhanced delivery of biologically active substances and compounds in an organism
|
|
EP0866805A1
(en)
|
1995-12-12 |
1998-09-30 |
Karolinska Innovations AB |
PEPTIDE BINDING THE KLVFF-SEQUENCE OF AMYLOID $g(b)
|
|
JPH09178743A
(ja)
|
1995-12-27 |
1997-07-11 |
Oriental Yeast Co Ltd |
可溶性ａｐｐの定量法
|
|
US5723125A
(en)
|
1995-12-28 |
1998-03-03 |
Tanox Biosystems, Inc. |
Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide
|
|
US6015662A
(en)
*
|
1996-01-23 |
2000-01-18 |
Abbott Laboratories |
Reagents for use as calibrators and controls
|
|
ZA97452B
(en)
*
|
1996-01-25 |
1997-08-15 |
Trinity College Dublin |
Streptococcus equi vaccine.
|
|
US5770700A
(en)
|
1996-01-25 |
1998-06-23 |
Genetics Institute, Inc. |
Liquid factor IX formulations
|
|
JPH09208485A
(ja)
|
1996-01-31 |
1997-08-12 |
Teijin Ltd |
ペプチド・蛋白質性薬物の水難溶性組成物
|
|
US6096313A
(en)
|
1996-02-09 |
2000-08-01 |
Ludwig Institute For Cancer Research |
Compositions containing immunogenic molecules and granulocyte-macrophage colony stimulating factor, as an adjuvant
|
|
WO1997032017A1
(en)
|
1996-02-26 |
1997-09-04 |
Morphosys Gesellschaft Für Proteinoptimierung Mbh |
Novel method for the identification of nucleic acid sequences encoding two or more interacting (poly)peptides
|
|
US6150091A
(en)
|
1996-03-06 |
2000-11-21 |
Baylor College Of Medicine |
Direct molecular diagnosis of Friedreich ataxia
|
|
US6372225B1
(en)
|
1996-03-23 |
2002-04-16 |
The Research Foundation Of Microbial Diseases Of Osaka University |
Tetanus toxin functional fragment antigen and tetanus vaccine
|
|
AU2182697A
(en)
|
1996-03-29 |
1997-10-22 |
University Of Otago |
Parapoxvirus vectors
|
|
US5837829A
(en)
|
1996-04-02 |
1998-11-17 |
Abbott Laboratories |
9-oximesilyl erythromycin a derivatives
|
|
EP0954324A4
(en)
|
1996-04-03 |
2000-11-02 |
Anergen Inc |
CYCLIC PEPTID VACCINES FOR DIABETES TREATMENT AND PREVENTION
|
|
JP2002506419A
(ja)
|
1996-04-19 |
2002-02-26 |
アメリカ合衆国 |
Ａ型肝炎ウイルスポリタンパク質の抗原反応性領域
|
|
US6284533B1
(en)
|
1996-05-01 |
2001-09-04 |
Avant Immunotherapeutics, Inc. |
Plasmid-based vaccine for treating atherosclerosis
|
|
DE69726003T2
(de)
|
1996-07-16 |
2004-08-26 |
Andreas Plückthun |
Immunglobulin-superfamilie domainen und fragmente mit erhöhter löslichkeit
|
|
JP2000516090A
(ja)
|
1996-07-26 |
2000-12-05 |
スローン―ケッタリング インスティチュート フォー キャンサー リサーチ |
遺伝子的免疫化のための方法と試薬
|
|
US7147851B1
(en)
|
1996-08-15 |
2006-12-12 |
Millennium Pharmaceuticals, Inc. |
Humanized immunoglobulin reactive with α4β7 integrin
|
|
CA2183901A1
(en)
|
1996-08-22 |
1998-02-23 |
Johanna E. Bergmann |
Targets for therapy and diagnosis of alzheimer's disease and down syndrome in humans
|
|
GB9617616D0
(en)
|
1996-08-22 |
1996-10-02 |
Osteometer Biotech As |
Assaying protein fragments in body fluids
|
|
EP1586584A1
(en)
|
1996-08-27 |
2005-10-19 |
Praecis Pharmaceuticals Incorporated |
Modulators of beta-amyloid peptide aggregation comprising D-amino acids
|
|
US6057367A
(en)
*
|
1996-08-30 |
2000-05-02 |
Duke University |
Manipulating nitrosative stress to kill pathologic microbes, pathologic helminths and pathologically proliferating cells or to upregulate nitrosative stress defenses
|
|
US6797495B2
(en)
|
1996-11-05 |
2004-09-28 |
The Regents Of The University Of California |
Somatic cells with ablated PrP gene and methods of use
|
|
US6022859A
(en)
*
|
1996-11-15 |
2000-02-08 |
Wisconsin Alumni Research Foundation |
Inhibitors of β-amyloid toxicity
|
|
WO1998022120A1
(en)
|
1996-11-19 |
1998-05-28 |
The Wistar Institute Of Anatomy & Biology |
Diagnostic and therapeutic reagents for alzheimer's disease
|
|
AUPO390396A0
(en)
|
1996-11-29 |
1996-12-19 |
Csl Limited |
Novel promiscuous T helper cell epitopes
|
|
US6962984B2
(en)
|
1996-12-05 |
2005-11-08 |
Nihon University |
IgA nephropathy-related DNA
|
|
US20030068316A1
(en)
*
|
1997-02-05 |
2003-04-10 |
Klein William L. |
Anti-ADDL antibodies and uses thereof
|
|
US6218506B1
(en)
*
|
1997-02-05 |
2001-04-17 |
Northwestern University |
Amyloid β protein (globular assembly and uses thereof)
|
|
PT966447E
(pt)
|
1997-03-03 |
2003-07-31 |
Boehringer Ingelheim Pharma |
Moleculas pequenas uteis no tratamento de doencas inflamatorias
|
|
US6277375B1
(en)
|
1997-03-03 |
2001-08-21 |
Board Of Regents, The University Of Texas System |
Immunoglobulin-like domains with increased half-lives
|
|
US5798102A
(en)
|
1997-03-04 |
1998-08-25 |
Milkhaus Laboratory, Inc. |
Treatment of cardiomyopathy
|
|
AU753688B2
(en)
|
1997-03-10 |
2002-10-24 |
Ottawa Civic Loeb Research Institute |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
|
US6057098A
(en)
*
|
1997-04-04 |
2000-05-02 |
Biosite Diagnostics, Inc. |
Polyvalent display libraries
|
|
SI0994728T1
(sl)
|
1997-04-09 |
2009-02-28 |
Intellect Neurosciences Inc |
Rekombinantna protitelesa, specifična za beta-amiloidne konce, kodirana z DNA ter postopki za njihovo uporabo
|
|
US20020086847A1
(en)
|
1997-04-09 |
2002-07-04 |
Mindset Biopharmaceuticals (Usa) |
Recombinant antibodies specific for beta-amyloid ends, DNA encoding and methods of use thereof
|
|
US8173127B2
(en)
|
1997-04-09 |
2012-05-08 |
Intellect Neurosciences, Inc. |
Specific antibodies to amyloid beta peptide, pharmaceutical compositions and methods of use thereof
|
|
NZ337955A
(en)
|
1997-04-15 |
2000-09-29 |
Ferring Farma Lab |
Modified TNF-alpha and their use as vaccines
|
|
US6787319B2
(en)
|
1997-04-16 |
2004-09-07 |
American Home Products Corp. |
β-amyloid peptide-binding proteins and polynucleotides encoding the same
|
|
EP1003531B1
(en)
*
|
1997-05-20 |
2007-08-22 |
Ottawa Health Research Institute |
Processes for preparing nucleic acid constructs
|
|
ATE230277T1
(de)
|
1997-06-13 |
2003-01-15 |
Genentech Inc |
Stabilisierte antikörperformulierung
|
|
WO1999000150A2
(en)
|
1997-06-27 |
1999-01-07 |
Regents Of The University Of California |
Drug targeting of a peptide radiopharmaceutical through the primate blood-brain barrier in vivo with a monoclonal antibody to the human insulin receptor
|
|
IT1293511B1
(it)
|
1997-07-30 |
1999-03-01 |
Gentili Ist Spa |
Anticorpi monoclonali catalitici ad attivita' proteasica per la lisi selettiva della componente proteica di placche e aggregati correlati
|
|
IT1293510B1
(it)
|
1997-07-30 |
1999-03-01 |
Gentili Ist Spa |
Anticorpi monoclonali catalitici per la trasformazione in vivo di profarmaci di corticosteroidi
|
|
WO1999006545A2
(en)
|
1997-08-01 |
1999-02-11 |
MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. |
Composition and method for the detection of diseases associated with amyloid-like fibril or protein aggregate formation
|
|
WO1999006587A2
(en)
|
1997-08-01 |
1999-02-11 |
Morphosys Ag |
Novel method and phage for the identification of nucleic acid sequences encoding members of a multimeric (poly)peptide complex
|
|
AU734180B2
(en)
|
1997-08-29 |
2001-06-07 |
Antigenics Llc |
Compositions comprising the adjuvant qs-21 and polysorbate or cyclodextrin as excipient
|
|
US6175057B1
(en)
*
|
1997-10-08 |
2001-01-16 |
The Regents Of The University Of California |
Transgenic mouse model of alzheimer's disease and cerebral amyloid angiopathy
|
|
US6118044A
(en)
|
1997-11-14 |
2000-09-12 |
Sankyo Company, Limited |
Transgenic animal allergy models and methods for their use
|
|
US6750324B1
(en)
|
1997-12-02 |
2004-06-15 |
Neuralab Limited |
Humanized and chimeric N-terminal amyloid beta-antibodies
|
|
US6913745B1
(en)
*
|
1997-12-02 |
2005-07-05 |
Neuralab Limited |
Passive immunization of Alzheimer's disease
|
|
US7964192B1
(en)
|
1997-12-02 |
2011-06-21 |
Janssen Alzheimer Immunotherapy |
Prevention and treatment of amyloidgenic disease
|
|
US6923964B1
(en)
|
1997-12-02 |
2005-08-02 |
Neuralab Limited |
Active immunization of AScr for prion disorders
|
|
US7588766B1
(en)
|
2000-05-26 |
2009-09-15 |
Elan Pharma International Limited |
Treatment of amyloidogenic disease
|
|
US6787523B1
(en)
*
|
1997-12-02 |
2004-09-07 |
Neuralab Limited |
Prevention and treatment of amyloidogenic disease
|
|
US7790856B2
(en)
*
|
1998-04-07 |
2010-09-07 |
Janssen Alzheimer Immunotherapy |
Humanized antibodies that recognize beta amyloid peptide
|
|
US7179892B2
(en)
|
2000-12-06 |
2007-02-20 |
Neuralab Limited |
Humanized antibodies that recognize beta amyloid peptide
|
|
US6761888B1
(en)
*
|
2000-05-26 |
2004-07-13 |
Neuralab Limited |
Passive immunization treatment of Alzheimer's disease
|
|
US6710226B1
(en)
*
|
1997-12-02 |
2004-03-23 |
Neuralab Limited |
Transgenic mouse assay to determine the effect of Aβ antibodies and Aβ Fragments on alzheimer's disease characteristics
|
|
TWI239847B
(en)
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
|
US20080050367A1
(en)
*
|
1998-04-07 |
2008-02-28 |
Guriq Basi |
Humanized antibodies that recognize beta amyloid peptide
|
|
US6905686B1
(en)
*
|
1997-12-02 |
2005-06-14 |
Neuralab Limited |
Active immunization for treatment of alzheimer's disease
|
|
DE69831971T2
(de)
|
1997-12-03 |
2006-07-06 |
Neuralab Ltd., Flatts |
Unterdrückung von veränderungen in zusammenhang mit beta-amyloid bei alzheimer
|
|
NZ504711A
(en)
|
1997-12-03 |
2002-02-01 |
Fujisawa Pharmaceutical Co |
Soft-pellet drug and process for the preparation thereof
|
|
FR2777015B3
(fr)
|
1998-02-23 |
2000-09-15 |
Financ De Biotechnologie |
Procede et moyens pour l'obtention de modeles cellulaires et animaux de maladies neurodegeneratives
|
|
US6194551B1
(en)
|
1998-04-02 |
2001-02-27 |
Genentech, Inc. |
Polypeptide variants
|
|
US6528624B1
(en)
*
|
1998-04-02 |
2003-03-04 |
Genentech, Inc. |
Polypeptide variants
|
|
US20050059591A1
(en)
*
|
1998-04-07 |
2005-03-17 |
Neuralab Limited |
Prevention and treatment of amyloidogenic disease
|
|
US20050059802A1
(en)
|
1998-04-07 |
2005-03-17 |
Neuralab Ltd |
Prevention and treatment of amyloidogenic disease
|
|
WO1999055369A1
(en)
|
1998-04-28 |
1999-11-04 |
Smithkline Beecham Corporation |
Monoclonal antibodies with reduced immunogenicity
|
|
GB9809951D0
(en)
|
1998-05-08 |
1998-07-08 |
Univ Cambridge Tech |
Binding molecules
|
|
NO314086B1
(no)
|
1998-05-08 |
2003-01-27 |
Gemvax As |
Peptider og farmasöytiske sammensetninger inneholdende disse, nukleinsyresekvenser som koder for slike peptider, plasmider og virusvektoreromfattende slike DNA-sekvenser samt anvendelse av disse for fremstilling avfarmasöytiske preparater til
|
|
WO1999060021A2
(en)
|
1998-05-19 |
1999-11-25 |
Yeda Research And Development Co. Ltd. |
Use of activated t cells, nervous system-specific antigens for treating disorders of the nevrous system
|
|
ES2345746T3
(es)
|
1998-05-21 |
2010-09-30 |
University Of Tennessee Research Foundation |
Metodos para la eliminacion de amiloide usando anticuerpos antiamiloide.
|
|
US20030147882A1
(en)
|
1998-05-21 |
2003-08-07 |
Alan Solomon |
Methods for amyloid removal using anti-amyloid antibodies
|
|
US6432710B1
(en)
|
1998-05-22 |
2002-08-13 |
Isolagen Technologies, Inc. |
Compositions for regenerating tissue that has deteriorated, and methods for using such compositions
|
|
US6727349B1
(en)
*
|
1998-07-23 |
2004-04-27 |
Millennium Pharmaceuticals, Inc. |
Recombinant anti-CCR2 antibodies and methods of use therefor
|
|
KR100731820B1
(ko)
|
1998-10-05 |
2007-06-25 |
파멕사 에이/에스 |
치료적 백신화를 위한 새로운 방법
|
|
EP1150688A4
(en)
|
1998-10-19 |
2004-06-16 |
Yeda Res & Dev |
TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS BY NEGATIVE REGULATION OF THE AUTO-IMMUNE RESPONSE TO AUTOANTIGENS
|
|
US7112661B1
(en)
|
1998-10-30 |
2006-09-26 |
The Research Foundation Of State University Of New York |
Variable heavy chain and variable light chain regions of antibodies to human platelet glycoprotein Ib alpha
|
|
GB2348203B
(en)
|
1998-11-04 |
2002-06-19 |
Imp College Innovations Ltd |
Solube beta-forms of prion proteins, methods of preparation and use
|
|
ES2216509T3
(es)
|
1999-01-19 |
2004-10-16 |
PHARMACIA & UPJOHN COMPANY |
Procedimiento de envasado para sustancias medicinales sensibles a la oxidacion.
|
|
CA2361124A1
(en)
|
1999-01-22 |
2000-07-27 |
Matthew John During |
Vaccine-mediated treatment of neurological disorders
|
|
MY128897A
(en)
|
1999-02-05 |
2007-02-28 |
Samsung Electronics Co Ltd |
Image texture retrieving method and apparatus thereof
|
|
US7629311B2
(en)
*
|
1999-02-24 |
2009-12-08 |
Edward Lewis Tobinick |
Methods to facilitate transmission of large molecules across the blood-brain, blood-eye, and blood-nerve barriers
|
|
US20040038317A1
(en)
|
1999-03-15 |
2004-02-26 |
Kalobios, Inc. |
Breakpoint fusion fragment complementation system
|
|
US7282570B2
(en)
*
|
1999-04-20 |
2007-10-16 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
|
AU4529800A
(en)
|
1999-05-05 |
2000-11-21 |
Neurochem, Inc. |
Stereoselective antifibrillogenic peptides and peptidomimetics thereof
|
|
US6787637B1
(en)
*
|
1999-05-28 |
2004-09-07 |
Neuralab Limited |
N-Terminal amyloid-β antibodies
|
|
PE20010212A1
(es)
|
1999-06-01 |
2001-02-22 |
Neuralab Ltd |
Composiciones del peptido a-beta y procesos para producir las mismas
|
|
UA81216C2
(en)
|
1999-06-01 |
2007-12-25 |
|
Prevention and treatment of amyloid disease
|
|
US7510824B2
(en)
*
|
1999-06-02 |
2009-03-31 |
Nono Inc. |
Method of screening peptides useful in treating traumatic injury to the brain or spinal cord
|
|
JP5249482B2
(ja)
|
1999-06-16 |
2013-07-31 |
ボストン・バイオメデイカル・リサーチ・インステイテユート |
インビボのβ−アミロイドレベルの免疫学的制御
|
|
WO2001002855A1
(en)
|
1999-07-01 |
2001-01-11 |
Scios Inc. |
Prevention and treatment of amyloid-associated disorders
|
|
BR0012429A
(pt)
|
1999-07-15 |
2002-09-17 |
Genetics Inst |
Fórmulações para il-11
|
|
ATE283285T1
(de)
|
1999-08-04 |
2004-12-15 |
Univ Southern California |
Globularer aufbau vom amyloid-beta- protein und deren verwendungen
|
|
JP2003509020A
(ja)
|
1999-09-03 |
2003-03-11 |
ラモット・ユニバーシティ・オーソリティ・フォー・アプライド・リサーチ・アンド・インダストリアル・ディベロップメント・リミテッド |
プラーク形成疾患の診断、治療、予防に有用な薬剤、組成物、その使用法
|
|
US6294171B2
(en)
|
1999-09-14 |
2001-09-25 |
Milkhaus Laboratory, Inc. |
Methods for treating disease states comprising administration of low levels of antibodies
|
|
US6824780B1
(en)
|
1999-10-29 |
2004-11-30 |
Genentech, Inc. |
Anti-tumor antibody compositions and methods of use
|
|
HK1049279A1
(zh)
|
1999-11-29 |
2003-05-09 |
Neurochem (International) Limited |
预防及治疗阿尔茨海默病(早老性痴呆)及淀粉样蛋白有关的病之疫苗
|
|
US20020094335A1
(en)
|
1999-11-29 |
2002-07-18 |
Robert Chalifour |
Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases
|
|
EP1237930B1
(en)
|
1999-12-08 |
2006-11-08 |
Intellect Neurosciences, Inc. |
Chimeric amyloid beta peptides
|
|
US6399314B1
(en)
|
1999-12-29 |
2002-06-04 |
American Cyanamid Company |
Methods of detection of amyloidogenic proteins
|
|
WO2001062284A2
(en)
|
2000-02-21 |
2001-08-30 |
Pharmexa A/S |
Novel method for down-regulation of amyloid
|
|
HRP20020721B1
(en)
|
2000-02-21 |
2012-04-30 |
H. Lundbeck A/S |
Novel method for down-regulation of amyloid
|
|
EA006606B1
(ru)
|
2000-02-24 |
2006-02-24 |
Вашингтон Юниверсити |
Гуманизированное антитело и его фрагмент, взаимодействующие с бета-амилоидным пептидом, и способы их применения
|
|
AU2001253158A1
(en)
|
2000-04-05 |
2001-10-23 |
University Of Tennessee Research Corporation |
Methods of investigating, diagnosing, and treating amyloidosis
|
|
WO2001078777A2
(en)
|
2000-04-13 |
2001-10-25 |
Mossman, Sally |
Immunostimulant compositions comprising an aminoalkyl glucosaminide phosphate and qs-21
|
|
ATE286072T1
(de)
*
|
2000-05-22 |
2005-01-15 |
Univ New York |
Synthetische immunogene jedoch nicht amyloidogene peptide, die homolog zu amyloid beta sind und deren verwendung zur induktion einer immunantwort gegen amyloid beta und amyloidaggregate
|
|
CN1450908A
(zh)
|
2000-06-28 |
2003-10-22 |
普拉纳生物技术有限公司 |
神经毒性寡聚体
|
|
AU2001268005A1
(en)
|
2000-07-07 |
2002-01-21 |
Lars Lannfelt |
Prevention and treatment of alzheimer's disease
|
|
US20020009445A1
(en)
*
|
2000-07-12 |
2002-01-24 |
Yansheng Du |
Human beta-amyloid antibody and use thereof for treatment of alzheimer's disease
|
|
EP1172378A1
(en)
|
2000-07-12 |
2002-01-16 |
Richard Dr. Dodel |
Human beta-amyloid antibody and use thereof for treatment of alzheimer's disease
|
|
DE10038237A1
(de)
|
2000-08-04 |
2002-02-14 |
Aventis Res & Tech Gmbh & Co |
Verfahren zum Nachweis von Mutationen in Nucleotidsequenzen
|
|
US20030092145A1
(en)
|
2000-08-24 |
2003-05-15 |
Vic Jira |
Viral vaccine composition, process, and methods of use
|
|
WO2002021141A2
(en)
|
2000-09-06 |
2002-03-14 |
Aventis Pharma S.A. |
Methods and compositions for diseases associated with amyloidosis
|
|
IT1319277B1
(it)
|
2000-10-24 |
2003-09-26 |
Chiesi Farma Spa |
Proteine di fusione utili per il trattamento di immunizzazione dellamalattia di alzheimer.
|
|
IL139308A0
(en)
|
2000-10-26 |
2001-11-25 |
Marikovsky Moshe |
Peptides from amyloid precursor protein which inhibit tumor growth and metastasis
|
|
DE60128138T2
(de)
*
|
2000-11-02 |
2008-01-03 |
Cornell Research Foundation, Inc. |
In vivo multiphoton diagnostische detektion und bilddarstellung einer neurodegenerativen erkrankung
|
|
AU2002225772A1
(en)
|
2000-11-27 |
2002-06-03 |
Praecis Pharmaceuticals Inc. |
Therapeutic agents and methods of use thereof for treating an amyloidogenic disease
|
|
US7700751B2
(en)
|
2000-12-06 |
2010-04-20 |
Janssen Alzheimer Immunotherapy |
Humanized antibodies that recognize β-amyloid peptide
|
|
PE20020574A1
(es)
*
|
2000-12-06 |
2002-07-02 |
Wyeth Corp |
Anticuerpos humanizados que reconocen el peptido amiloideo beta
|
|
AU2002246734A1
(en)
|
2000-12-27 |
2002-08-12 |
University Of Texas Health Science Center Houston |
Prion isomers, methods of making, methods of using, and compositions and products comprising prion isomers
|
|
US20020160394A1
(en)
|
2001-01-24 |
2002-10-31 |
Bayer Corporation |
Regulation of transthyretin to treat obesity
|
|
EP1251138B1
(en)
|
2001-04-19 |
2006-07-26 |
Hermann Dr. Schätzl |
Prion protein dimers useful for vaccination
|
|
ATE409047T1
(de)
|
2001-04-30 |
2008-10-15 |
Lilly Co Eli |
Humanisierte antikörper
|
|
AU2002258808A1
(en)
|
2001-04-30 |
2002-11-11 |
Eli Lilly And Company |
Humanized antibodies
|
|
US6906169B2
(en)
|
2001-05-25 |
2005-06-14 |
United Biomedical, Inc. |
Immunogenic peptide composition comprising measles virus Fprotein Thelper cell epitope (MUFThl-16) and N-terminus of β-amyloid peptide
|
|
GB0113179D0
(en)
|
2001-05-31 |
2001-07-25 |
Novartis Ag |
Organic compounds
|
|
US20020197258A1
(en)
|
2001-06-22 |
2002-12-26 |
Ghanbari Hossein A. |
Compositions and methods for preventing protein aggregation in neurodegenerative diseases
|
|
ATE454137T1
(de)
|
2001-07-25 |
2010-01-15 |
Facet Biotech Corp |
Stabile lyophilisierte pharmazeutische formulierung des igg-antikörpers daclizumab
|
|
US20030135035A1
(en)
|
2001-08-09 |
2003-07-17 |
Mark Shannon |
Human ZZAP1 protein
|
|
EP1429805A4
(en)
*
|
2001-08-17 |
2005-09-21 |
Lilly Co Eli |
USE OF ANTIBODIES WITH HIGH AFFINITY FOR A $ G (B) PEPTIDE IN THE TREATMENT OF DISEASES AND DISEASES RELATED TO A $ G (B)
|
|
EP1519740A4
(en)
|
2001-08-17 |
2005-11-09 |
Lilly Co Eli |
FASTER IMPROVEMENT OF COGNITION IN DISEASES ASSOCIATED WITH A-BETA
|
|
WO2003016466A2
(en)
|
2001-08-17 |
2003-02-27 |
Eli Lilly And Company |
ANTI-Aβ ANTIBODIES
|
|
US20030082191A1
(en)
|
2001-08-29 |
2003-05-01 |
Poduslo Joseph F. |
Treatment for central nervous system disorders
|
|
EP1435774B1
(en)
*
|
2001-09-10 |
2010-08-25 |
AntiCancer, Inc. |
Enhanced resolution of tumor metastasis
|
|
US6907297B2
(en)
|
2001-09-28 |
2005-06-14 |
Ethicon, Inc. |
Expandable intracardiac return electrode and method of use
|
|
US7781413B2
(en)
|
2001-10-31 |
2010-08-24 |
Board Of Regents, The University Of Texas System |
SEMA3B inhibits tumor growth and induces apoptosis in cancer cells
|
|
US20030138417A1
(en)
|
2001-11-08 |
2003-07-24 |
Kaisheva Elizabet A. |
Stable liquid pharmaceutical formulation of IgG antibodies
|
|
EP1572894B1
(en)
|
2001-11-21 |
2016-04-13 |
New York University |
Synthetic immunogenic but non-deposit-forming polypeptides and peptides homologous to amyloid beta, prion protein, amylin, alpha synuclein, or polyglutamine repeats for induction of an immune response thereto
|
|
US20050227941A1
(en)
|
2001-12-17 |
2005-10-13 |
Karen Duff |
Sequestration of ass in the periphery in the absence of immunomodulating agent as a therapeutic approach for the treatment or prevention of beta-amyloid related diseases
|
|
US7432063B2
(en)
|
2002-02-14 |
2008-10-07 |
Kalobios Pharmaceuticals, Inc. |
Methods for affinity maturation
|
|
US7335478B2
(en)
|
2002-04-18 |
2008-02-26 |
Kalobios Pharmaceuticals, Inc. |
Reactivation-based molecular interaction sensors
|
|
US20030157579A1
(en)
|
2002-02-14 |
2003-08-21 |
Kalobios, Inc. |
Molecular sensors activated by disinhibition
|
|
AR038568A1
(es)
|
2002-02-20 |
2005-01-19 |
Hoffmann La Roche |
Anticuerpos anti-a beta y su uso
|
|
EP1476120B1
(en)
|
2002-02-21 |
2010-09-29 |
Duke University |
Treatment methods using anti-cd22 antibodies
|
|
MY139983A
(en)
|
2002-03-12 |
2009-11-30 |
Janssen Alzheimer Immunotherap |
Humanized antibodies that recognize beta amyloid peptide
|
|
US20040038304A1
(en)
|
2002-03-28 |
2004-02-26 |
Gala Design, Inc. |
Antibody libraries
|
|
US7132100B2
(en)
|
2002-06-14 |
2006-11-07 |
Medimmune, Inc. |
Stabilized liquid anti-RSV antibody formulations
|
|
BR0312792A
(pt)
|
2002-07-19 |
2005-05-03 |
Cytos Biotechnology Ag |
Composições de vacinas contendo séries antigênicas de amilóide beta1-6
|
|
WO2004013172A2
(en)
|
2002-07-24 |
2004-02-12 |
Innogenetics N.V. |
Fragments of beta-amyloid as targets for vaccination against alzheimer disease
|
|
US6827524B2
(en)
*
|
2002-07-26 |
2004-12-07 |
Ingersoll-Rand Company |
Controller for a compacting vehicle wetting system
|
|
DK1529116T3
(da)
|
2002-08-07 |
2009-11-09 |
Novartis Ag |
Fremgangsmåde til forudsigelse af respons på behandling med rivastigmin baseret på ApoE-genotypen hos demenspatienter
|
|
US6802134B2
(en)
|
2002-08-09 |
2004-10-12 |
Patrick J. Allen |
Tapered sliding dovetail tool and kit including such tool
|
|
WO2004029629A1
(en)
|
2002-09-27 |
2004-04-08 |
Janssen Pharmaceutica N.V. |
N-11 truncated amyloid-beta nomoclonal antibodies, compositions, methods and uses
|
|
JP2006508072A
(ja)
|
2002-10-01 |
2006-03-09 |
ノースウエスタン ユニバーシティ |
アミロイドベータ由来拡散性リガンド（ＡＤＤＬｓ）、ＡＤＤＬ代替物、ＡＤＤＬ結合性分子、およびそれらの使用
|
|
AU2003279216A1
(en)
|
2002-10-09 |
2004-05-04 |
Rinat Neuroscience Corp. |
Methods of treating alzheimer's disease using antibodies directed against amyloid beta peptide and compositions thereof
|
|
US7365168B2
(en)
|
2002-10-15 |
2008-04-29 |
Pdl Biopharma, Inc. |
Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis
|
|
US20060019850A1
(en)
*
|
2002-10-31 |
2006-01-26 |
Korzenski Michael B |
Removal of particle contamination on a patterned silicon/silicon dioxide using dense fluid/chemical formulations
|
|
FR2846667B1
(fr)
|
2002-11-06 |
2004-12-31 |
Pasteur Institut |
Fragments variables d'anticorps de camelides a chaine unique diriges contre le peptide beta-amyloide 1-42 et leurs applications pour le diagnostic et le traitement des maladies neuroagregatives
|
|
AU2003293543A1
(en)
|
2002-12-13 |
2004-07-09 |
Abgenix, Inc. |
System and method for stabilizing antibodies with histidine
|
|
US6787129B1
(en)
|
2003-01-13 |
2004-09-07 |
Zenitech Llc |
Castor polyester as gloss agents in anionic systems
|
|
KR20050118669A
(ko)
|
2003-02-01 |
2005-12-19 |
뉴랄랩 리미티드 |
가용성 ａ-베타에 대한 항체를 생성하기 위한 능동 면역화
|
|
ES2344645T3
(es)
|
2003-02-10 |
2010-09-02 |
Applied Molecular Evolution, Inc. |
Moleculas de union al abeta.
|
|
WO2004072266A2
(en)
|
2003-02-13 |
2004-08-26 |
Kalobios Inc. |
Antibody affinity engineering by serial epitope-guided complementarity replacement
|
|
US20040242845A1
(en)
|
2003-02-21 |
2004-12-02 |
Nicolau Yves Claude |
Methods and compositions comprising supramolecular antigenic constructs and antibodies elicited against them
|
|
US8663650B2
(en)
|
2003-02-21 |
2014-03-04 |
Ac Immune Sa |
Methods and compositions comprising supramolecular constructs
|
|
CA2520853A1
(en)
|
2003-03-28 |
2005-03-31 |
Centocor, Inc. |
Anti-amyloid antibodies, compositions, methods and uses
|
|
PT1610820E
(pt)
|
2003-04-04 |
2010-12-16 |
Novartis Ag |
Formulações de elevada concentração de anticorpos e proteínas
|
|
EP1480041A1
(en)
|
2003-05-22 |
2004-11-24 |
Innogenetics N.V. |
Method for the prediction, diagnosis and differential diagnosis of Alzheimer's disease
|
|
TWI306458B
(en)
|
2003-05-30 |
2009-02-21 |
Elan Pharma Int Ltd |
Humanized antibodies that recognize beta amyloid peptide
|
|
WO2004106375A1
(en)
|
2003-05-30 |
2004-12-09 |
Merus Biopharmaceuticals B.V. I.O. |
Fab library for the preparation of anti vegf and anti rabies virus fabs
|
|
WO2005002444A1
(en)
|
2003-07-07 |
2005-01-13 |
Agency For Science, Technology And Research |
Method and apparatus for extracting third ventricle information
|
|
WO2005014041A2
(en)
|
2003-07-24 |
2005-02-17 |
Novartis Ag |
Use of an amyloid beta dna vaccine for the treatment and/or prevention of amyloid diseases
|
|
WO2005012330A2
(en)
|
2003-07-30 |
2005-02-10 |
Brigham And Women's Hospital, Inc. |
AMYLOID β-PEPTIDE AND METHODS OF USE
|
|
US20060233788A1
(en)
|
2003-09-05 |
2006-10-19 |
Heiman Mark L |
Anti-ghrelin antibodies
|
|
CA2445743A1
(en)
|
2003-10-08 |
2005-04-08 |
The University Of British Columbia |
Methods for modulating neuronal responses
|
|
AU2003271174A1
(en)
|
2003-10-10 |
2005-04-27 |
Chugai Seiyaku Kabushiki Kaisha |
Double specific antibodies substituting for functional protein
|
|
SG149013A1
(en)
|
2003-12-17 |
2009-01-29 |
Wyeth Corp |
Immunogenic peptide carrier conjugates and methods of producing same
|
|
SI2336147T1
(sl)
*
|
2003-12-17 |
2014-08-29 |
Janssen Alzheimer Immunotherapy |
Konjugati nosilcev a beta imunogenih peptidov in postopki izdelave istih
|
|
EP1702071B1
(en)
|
2003-12-31 |
2012-02-22 |
Kalobios Inc. |
Transactivation system for mammalian cells
|
|
US7981843B2
(en)
|
2004-01-20 |
2011-07-19 |
Kalobios Pharmaceuticals, Inc. |
Antibody specificity transfer using minimal essential binding determinants
|
|
US20050214222A1
(en)
|
2004-02-13 |
2005-09-29 |
Mckinnon Stuart J |
In vivo imaging of amyloid plaques in glaucoma using intravenous injectable dyes
|
|
US7807157B2
(en)
|
2004-02-20 |
2010-10-05 |
Intellect Neurosciences Inc. |
Monoclonal antibodies and use thereof
|
|
KR101166342B1
(ko)
|
2004-03-15 |
2012-07-18 |
얀센 파마슈티카 엔.브이. |
아편계 약물 수용체 조절자로서의 신규의 화합물
|
|
FR2871633A1
(fr)
|
2004-06-10 |
2005-12-16 |
France Telecom |
Procede de reduction du bruit de phase lors de la reception d'un signal ofdm, recepteur, programme et support
|
|
SE0401601D0
(sv)
|
2004-06-21 |
2004-06-21 |
Bioarctic Neuroscience Ab |
Protofibril specific antibodies and uses thereof
|
|
DK1771208T3
(da)
|
2004-07-02 |
2013-09-02 |
Univ Pittsburgh |
Anvendelse af thioflavin radiomarkerede derivater i amyloid billeddannelse til vurdering af anti-amyloide terapier
|
|
AT413946B
(de)
|
2004-07-13 |
2006-07-15 |
Mattner Frank Dr |
Impfstoff gegen die alzheimer-krankheit
|
|
EP2083291B1
(en)
|
2004-07-13 |
2012-07-04 |
Fujikura, Ltd. |
Low bending loss multimode holey fiber
|
|
AU2005290250A1
(en)
*
|
2004-07-30 |
2006-04-06 |
Rinat Neuroscience Corp. |
Antibodies directed against amyloid-beta peptide and methods using same
|
|
CA2578131A1
(en)
*
|
2004-09-10 |
2006-03-23 |
Wyeth |
Humanized anti-5t4 antibodies and anti-5t4 antibody/calicheamicin conjugates
|
|
US20090247931A1
(en)
|
2004-09-23 |
2009-10-01 |
Novo Nordisk A/S |
Device for self-care support
|
|
CN1276024C
(zh)
|
2004-09-30 |
2006-09-20 |
北京科技大学 |
含缺陷管道修复补强的碳纤维复合材料和方法
|
|
EA200700751A1
(ru)
*
|
2004-10-05 |
2008-06-30 |
Элан Фарма Интернэшнл Лимитед |
Способы и композиции для улучшения продуцирования рекомбинантного белка
|
|
WO2006047670A2
(en)
*
|
2004-10-26 |
2006-05-04 |
Wyeth |
Methods for assessing antibodies to neurodegenerative disease-associated antigens
|
|
PL2343380T3
(pl)
|
2004-11-16 |
2020-03-31 |
Humanigen, Inc. |
Wymiana kasety dla regionu zmiennego immunoglobuliny
|
|
EP1838348B1
(en)
|
2004-12-15 |
2013-06-26 |
Janssen Alzheimer Immunotherapy |
Humanized amyloid beta antibodies for use in improving cognition
|
|
WO2006066233A1
(en)
|
2004-12-15 |
2006-06-22 |
Neuralab Limited |
An immunoprecipitation-based assay for predicting in vivo efficacy of beta-amyloid antibodies
|
|
US20060153772A1
(en)
*
|
2004-12-15 |
2006-07-13 |
Wyeth |
Contextual fear conditioning for predicting immunotherapeutic efficacy
|
|
ES2396555T3
(es)
|
2004-12-15 |
2013-02-22 |
Janssen Alzheimer Immunotherapy |
Anticuerpos que reconocen péptido beta amiloide
|
|
US20060257396A1
(en)
*
|
2004-12-15 |
2006-11-16 |
Jacobsen Jack S |
Abeta antibodies for use in improving cognition
|
|
WO2006081171A1
(en)
|
2005-01-24 |
2006-08-03 |
Amgen Inc. |
Humanized anti-amyloid antibody
|
|
GT200600031A
(es)
*
|
2005-01-28 |
2006-08-29 |
|
Formulacion anticuerpo anti a beta
|
|
PA8661401A1
(es)
|
2005-01-28 |
2006-09-08 |
Wyeth Corp |
Formulaciones del liquido polipeptido estabilizado
|
|
US7731962B2
(en)
|
2005-02-14 |
2010-06-08 |
Merck & Co., Inc. |
Anti-ADDL monoclonal antibody and use thereof
|
|
PE20061323A1
(es)
|
2005-04-29 |
2007-02-09 |
Rinat Neuroscience Corp |
Anticuerpos dirigidos contra el peptido amiloide beta y metodos que utilizan los mismos
|
|
WO2006121656A2
(en)
|
2005-05-05 |
2006-11-16 |
Merck & Co., Inc. |
Peptide conjugate compositions and methods for the prevention and treatment of alzheimer's disease
|
|
BRPI0611600B8
(pt)
|
2005-06-17 |
2021-05-25 |
Wyeth Corp |
método para purificação de uma proteína tendo uma região fc a partir de um líquido fonte compreendendo a proteína e uma ou mais impurezas, e kit
|
|
CA2615656A1
(en)
*
|
2005-07-18 |
2007-01-25 |
Merck & Co., Inc. |
Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease
|
|
US8211648B2
(en)
|
2005-07-22 |
2012-07-03 |
Kalobios Pharmaceuticals, Inc. |
Secretion of antibodies without signal peptides from bacteria
|
|
CA2622772A1
(en)
|
2005-09-29 |
2007-04-12 |
Viral Logic Systems Technology Corp. |
Immunomodulatory compositions and uses therefor
|
|
CN105245249B
(zh)
|
2005-10-04 |
2018-12-14 |
华为技术有限公司 |
移动台装置、基站装置、寻呼方法
|
|
JP2009516654A
(ja)
*
|
2005-11-10 |
2009-04-23 |
ロスキャンプ リサーチ， エルエルシー |
Ａ−ベータペプチドによる血管新生の調節
|
|
WO2007062088A1
(en)
|
2005-11-22 |
2007-05-31 |
The Trustees Of The University Of Pennsylvania |
Antibody treatment of alzheimer's and related diseases
|
|
NZ568012A
(en)
|
2005-12-12 |
2012-07-27 |
Ac Immune Sa |
A beta 1-42 specific monoclonal antibodies with therapeutic properties
|
|
KR101263294B1
(ko)
|
2006-03-30 |
2013-06-04 |
글락소 그룹 리미티드 |
아밀로이드베타 펩티드에 대한 항체
|
|
US8784810B2
(en)
|
2006-04-18 |
2014-07-22 |
Janssen Alzheimer Immunotherapy |
Treatment of amyloidogenic diseases
|
|
WO2010044803A1
(en)
|
2008-10-17 |
2010-04-22 |
Elan Pharma International Limited |
Treatment of amyloidogenic diseases
|
|
TWI305843B
(en)
*
|
2006-04-24 |
2009-02-01 |
Young Optics Inc |
Dlp projection apparatus
|
|
RU2498999C2
(ru)
|
2006-07-14 |
2013-11-20 |
Ац Иммуне Са |
Гуманизированное антитело к амилоиду бета
|
|
CA2680762A1
(en)
|
2007-03-12 |
2008-09-25 |
National Institute Of Radiological Sciences |
Pet visualization of amyloid-associated neuroinflammation in the brain
|
|
WO2008131298A2
(en)
*
|
2007-04-18 |
2008-10-30 |
Elan Pharma International Limited |
Prevention and treatment of cerebral amyloid angiopathy
|
|
US8003097B2
(en)
|
2007-04-18 |
2011-08-23 |
Janssen Alzheimer Immunotherapy |
Treatment of cerebral amyloid angiopathy
|
|
ES2498040T3
(es)
|
2007-07-27 |
2014-09-24 |
Janssen Alzheimer Immunotherapy |
Tratamiento de enfermedades amiloidogénicas con anticuerpos anti-beta humanizados
|
|
JO3076B1
(ar)
|
2007-10-17 |
2017-03-15 |
Janssen Alzheimer Immunotherap |
نظم العلاج المناعي المعتمد على حالة apoe
|
|
WO2011133919A1
(en)
|
2010-04-22 |
2011-10-27 |
Janssen Alzheimer Immunotherapy |
Use of tau to monitor immunotherapy
|
|
WO2009086539A2
(en)
*
|
2007-12-28 |
2009-07-09 |
Elan Pharmaceuticals, Inc. |
Treatment and prophylaxis of amyloidosis
|
|
WO2010033861A1
(en)
|
2008-09-18 |
2010-03-25 |
Cedars-Sinai Medical Center |
Optical method for the detection of alzheimer's disease
|
|
WO2011106732A1
(en)
|
2010-02-25 |
2011-09-01 |
Wyeth Llc |
Pet monitoring of ab-directed immunotherapy
|
|
US8689528B1
(en)
|
2011-11-08 |
2014-04-08 |
Seda Gaspari |
Method of packaging a plurality of tissues for dispensing
|